These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1040 related items for PubMed ID: 10763956

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Surface enhanced laser desorption/ionization profiling: New diagnostic method of HBV-related hepatocellular carcinoma.
    Wu C, Wang Z, Liu L, Zhao P, Wang W, Yao D, Shi B, Lu J, Liao P, Yang Y, Zhu L.
    J Gastroenterol Hepatol; 2009 Jan; 24(1):55-62. PubMed ID: 18823443
    [Abstract] [Full Text] [Related]

  • 23. Use of serum PIVKA-II (DCP) determination for differentiation between benign and malignant liver diseases.
    Lamerz R, Runge M, Stieber P, Meissner E.
    Anticancer Res; 1999 Jan; 19(4A):2489-93. PubMed ID: 10470180
    [Abstract] [Full Text] [Related]

  • 24. Usefulness of simultaneous determination of alpha-fetoprotein and des-gamma-carboxy prothrombin in hepatocellular carcinoma.
    Nakao A, Taniguchi K, Inoue S, Harada A, Nonami T, Watanabe K, Takagi H.
    Semin Surg Oncol; 1996 Jan; 12(3):160-3. PubMed ID: 8727604
    [Abstract] [Full Text] [Related]

  • 25. Clinical significance of simultaneous determinations of alpha-fetoprotein and des-gamma-carboxy prothrombin in monitoring recurrence in patients with hepatocellular carcinoma.
    Aoyagi Y, Oguro M, Yanagi M, Mita Y, Suda T, Suzuki Y, Hata K, Ichii K, Asakura H.
    Cancer; 1996 May 01; 77(9):1781-6. PubMed ID: 8646674
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Significance of alpha-fetoprotein and des-gamma-carboxy prothrombin in patients with hepatocellular carcinoma undergoing hepatectomy.
    Yamamoto K, Imamura H, Matsuyama Y, Hasegawa K, Beck Y, Sugawara Y, Makuuchi M, Kokudo N.
    Ann Surg Oncol; 2009 Oct 01; 16(10):2795-804. PubMed ID: 19669841
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Utility of alpha-fetoprotein (AFP) in the screening of patients with virus-related chronic liver disease: does different viral etiology influence AFP levels in HCC? A study in 350 western patients.
    Cedrone A, Covino M, Caturelli E, Pompili M, Lorenzelli G, Villani MR, Valle D, Sperandeo M, Rapaccini GL, Gasbarrini G.
    Hepatogastroenterology; 2000 Oct 01; 47(36):1654-8. PubMed ID: 11149026
    [Abstract] [Full Text] [Related]

  • 32. Determination of serum des-gamma-carboxy prothrombin levels in patients with small-sized hepatocellular carcinoma: comparison of the conventional enzyme immunoassay and two modified methods.
    Nomura F, Ishijima M, Horikoshi A, Nakai T, Ohnishi K.
    Am J Gastroenterol; 1996 Jul 01; 91(7):1380-3. PubMed ID: 8677999
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Clinical evaluation of plasma abnormal prothrombin (PIVKA-II) in patients with hepatocellular carcinoma.
    Fujiyama S, Morishita T, Sagara K, Sato T, Motohara K, Matsuda I.
    Hepatogastroenterology; 1986 Oct 01; 33(5):201-5. PubMed ID: 2433199
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Preoperative tumor marker doubling time is a useful predictor of recurrence and prognosis after hepatic resection of hepatocellular carcinoma.
    Masuda T, Beppu T, Horino K, Komori H, Hayashi H, Okabe H, Otao R, Horlad H, Ishiko T, Takamori H, Kikuchi K, Baba H.
    J Surg Oncol; 2010 Oct 01; 102(5):490-6. PubMed ID: 19937994
    [Abstract] [Full Text] [Related]

  • 37. Squamous cell carcinoma antigen-immunoglobulin M complexes as novel biomarkers for hepatocellular carcinoma.
    Beneduce L, Castaldi F, Marino M, Quarta S, Ruvoletto M, Benvegnù L, Calabrese F, Gatta A, Pontisso P, Fassina G.
    Cancer; 2005 Jun 15; 103(12):2558-65. PubMed ID: 15887222
    [Abstract] [Full Text] [Related]

  • 38. Serum des-gamma-carboxyprothrombin level by a modified enzyme immunoassay method in hepatocellular carcinoma: clinical significance in small hepatocellular carcinoma.
    Soga K, Watanabe T, Aikawa K, Toshima M, Shibasaki K, Aoyagi Y.
    Hepatogastroenterology; 1998 Jun 15; 45(23):1737-41. PubMed ID: 9840138
    [Abstract] [Full Text] [Related]

  • 39. Are both PIVKA-II and alpha-fetoprotein necessary in follow-up management after hepatic resection for hepatocellular carcinoma?
    Koh T, Taniguchi H, Katoh H, Kunishima S, Yamaguchi A, Yamagishi H.
    Hepatogastroenterology; 2002 Jun 15; 49(48):1615-8. PubMed ID: 12397748
    [Abstract] [Full Text] [Related]

  • 40. Serum des-gamma-carboxy prothrombin levels determined by a new generation of sensitive immunoassays in patients with small-sized hepatocellular carcinoma.
    Nomura F, Ishijima M, Kuwa K, Tanaka N, Nakai T, Ohnishi K.
    Am J Gastroenterol; 1999 Mar 15; 94(3):650-4. PubMed ID: 10086646
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 52.